IN
INDCT.OL Induct AS
- Market cap
- NOK 24.9M
- P/E
- -
- P/B
- 0.71x
- ROE
- -23.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is INDCT.OL undervalued?
Graham numberThe Graham number of Induct AS cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Induct AS fundamental analysis
No fundamental analysis for Induct AS yet.
Induct AS stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Induct AS
Induct AS develops management software in Norway and internationally. The company offers care pathway platform, a disease specific SaS platform; grant platforms; innovation management; and induct.net platform. Induct AS was founded in 2007 and is headquartered in Oslo, Norway.
Full company profileInduct AS financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Induct AS annual financial statements (NOK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 6.81M | 12.3M | 14.8M | 13.8M | 11.6M | 15.2M | 18.2M | 23.5M | 19.8M | 16.6M | 12.3M |
| Gross Profit | 4.69M | 10.8M | 10.6M | 13.6M | 11.2M | 13.4M | 17.5M | 22.4M | 18.5M | 15.9M | 11.9M |
| Operating Income | -9.99M | -13.1M | -10.4M | -5.69M | -1.73M | -549K | -6.35M | -3.03M | -16.9M | -5.30M | -7.90M |
| EBITDA | - | -10.7M | -7.67M | -2.49M | 1.04M | 4.86M | 7.22M | 8.12M | -4.00M | 7.27M | 4.53M |
| Net Income | -11.3M | -13.5M | -13.4M | -6.27M | -2.16M | -2.45M | -10.3M | -4.99M | -20.6M | -7.14M | -8.57M |
| EPS | -1.55 | -1.65 | -1.40 | -0.58 | -0.16 | -0.18 | -0.59 | -0.26 | -0.87 | -0.23 | -0.27 |
| Balance Sheet | |||||||||||
| Total Assets | 18.2M | 20.5M | 18.5M | 18.4M | 22.0M | 80.3M | 92.2M | 67.3M | 61.3M | 56.5M | 52.0M |
| Total Liabilities | 11.1M | 13.2M | 17.0M | 15.6M | 17.1M | 65.0M | 62.7M | 44.6M | 34.8M | 14.8M | 15.1M |
| Shareholders' Equity | 7.08M | 7.37M | 1.53M | 2.81M | 4.91M | 15.4M | 29.5M | 22.8M | 26.5M | 41.8M | 36.9M |
| Cash & Short-term Investments | 2.39M | 1.63M | 1.97M | 1.54M | 3.77M | 3.73M | 2.56M | 900K | 441K | 2.66M | 957K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -26.0M | -13.7M | -4.23M | -6.69M | 1.96M | -1.51M | -10.0M | 4.33M | -1.59M | 4.44M | - |
| Capital Expenditure | 1.47M | 3.63M | 4.37M | 2.92M | 4.02M | 11.2M | 15.3M | 11.0M | 4.47M | 7.74M | 0.00 |
| Free Cash Flow | - | -17.3M | -8.59M | -9.61M | -2.06M | -12.7M | -25.4M | -6.70M | -6.06M | -3.30M | - |
| Ratios | |||||||||||
| ROE | -159.9% | -183.3% | -876.6% | -223.4% | -44.0% | -16.0% | -34.8% | -21.9% | -77.8% | -17.1% | -23.2% |
| ROA | -62.3% | -65.8% | -72.5% | -34.0% | -9.8% | -3.1% | -11.1% | -7.4% | -33.6% | -12.6% | -16.5% |
| Net Profit Margin | -166.2% | -110.3% | -90.6% | -45.5% | -18.6% | -16.1% | -56.6% | -21.3% | -104.2% | -43.1% | -69.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Induct AS dividends
Induct AS has not paid dividends in the last 9 fiscal years.
Who owns Induct AS
- Insiders 39.20%
- Institutions 1.68%
- Public & others 59.12%
- Shares outstanding 50.3M
- Free float 29.6M
Induct AS company profile
- Company name
- Induct AS
- Ticker
- INDCT.OL
- ISIN
- NO0010536048
- Exchange
- Oslo Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 13
- Fiscal year end
- December
- Address
- Cort Adelers gate 17, Oslo, Norway, 0254
- Phone
- 47 41 58 00 00
- Website
- web.induct.net
About Induct AS
Induct AS develops management software in Norway and internationally. The company offers care pathway platform, a disease specific SaS platform; grant platforms; innovation management; and induct.net platform. Induct AS was founded in 2007 and is headquartered in Oslo, Norway.
Induct AS management
8- Synnove JacobsenChief Executive Officer
- Mr. Karl Erik BrotenChief Financial Officer · born 1967
- Mr. Kenneth RambergChief Technology Officer
- Mr. Kim HamliChief Commercial Officer
- Ms. Lise KagenowManaging Director of UK
- Mr. Varadarajan KrishnaManaging Director of India
- Mr. Rafael Rocha LevyManaging Director of Brazil
- Mr. Joan RasManaging Director of Spain